Impaired type I interferon signaling activity implicated in the peripheral blood transcriptome of preclinical Alzheimer's disease
eBioMedicine(2022)
摘要
Background Subjective or objective subtle cognitive decline (SCD) is considered the preclinical manifestation of Alzheimer's disease (AD), which is a potentially crucial window for preventing or delaying the progression of the disease. Methods To explore the potential mechanism of disease progression and identify relevant biomarkers, we compre-hensively assessed the peripheral blood transcriptomic alterations in SCD, covering lncRNA, mRNA, and miRNA. Findings Dysregulated protein-coding mRNA at both gene and isoform levels implicated impairment in the type I interferon signaling pathway in SCD. Specifically, this pathway was regulated by the transcription factor STAT1 and ncRNAs NRIR and has-miR-146a-5p. The miRNA-mRNA-lncRNA co-expression network revealed hub genes for the interferon module. Individuals with lower interferon signaling activity and lower expression of a hub gene STAT1 exhibited a higher conversion rate to mild cognitive impairment (MCI). Interpretation Our findings illustrated the down-regulation of interferon signaling activity would potentially increase the risk of disease progression and thus serve as a pre-disease biomarker.Copyright (c) 2022 The Authors. Published by Elsevier B.V.
更多查看译文
关键词
Subjective or objective subtle cognitive decline (SCD),Alzheimer's disease (AD),Peripheral blood transcriptome,Type I interferon signaling,Progression biomarkers
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要